MARKET UPDATE
Advertisement Topt

TheCable

Tag "High efficacy"

‘High efficacy and cost-effective’ — WHO approves Oxford malaria vaccine for use in children

    ‘High efficacy and cost-effective’ — WHO approves Oxford malaria vaccine for use in children

The World Health Organisation (WHO) says it approved R21/Matrix-M, a malaria vaccine, developed by scientists at Oxford University, for the prevention of the disease in children. In a statement on

0 comment Read Full Article
error: Content is protected from copying.